(19)
(11) EP 4 771 172 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24772485.9

(22) Date of filing: 27.08.2024
(51) International Patent Classification (IPC): 
C12Q 1/6806(2018.01)
C12Q 1/70(2006.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/705; C12Q 1/6806; C12Q 1/70
 
C-Sets:
C12Q 1/70, C12Q 2563/149, C12Q 2563/143;
(86) International application number:
PCT/US2024/044002
(87) International publication number:
WO 2025/049451 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 28.08.2023 US 202363534934 P
12.03.2024 US 202463564277 P

(71) Applicant: Abbott Molecular Inc.
Des Plaines, IL 60018 (US)

(72) Inventors:
  • TOOLSIE, Dan R.
    Des Plaines, Illinois 60018 (US)
  • HUANG, Shihai
    Des Plaines, Illinois 60018 (US)
  • LENNON, Frances
    Des Plaines, Illinois 60018 (US)
  • WANG, Xin
    Des Plaines, Illinois 60018 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) ASSAYS FOR DETECTING CYTOMEGALOVIRUS (CMV) OR EPSTEIN-BAR VIRUS (EBV)